Professional Documents
Culture Documents
Boosting Fluorescence-Photoacoustic-Raman
Properties in One Fluorophore for Precise
Cancer Surgery
Ji Qi, Jun Li, Ruihua Liu, ...,
Dingbin Liu, Dan Ding, Ben
Zhong Tang
dingd@nankai.edu.cn (D.D.)
tangbenz@ust.hk (B.Z.T.)
HIGHLIGHTS
Fluorescence, photoacoustic, and
Raman properties can be boosted
in one molecule
Preoperative fluorescence/PA
imaging deciphers
comprehensive tumor information
Intraoperative fluorescence/
Raman imaging helps to delineate
tiny residual tumors
Article
Boosting Fluorescence-Photoacoustic-Raman
Properties in One Fluorophore
for Precise Cancer Surgery
Ji Qi,1,5 Jun Li,2,5 Ruihua Liu,2 Qiang Li,3 Haoke Zhang,1 Jacky W.Y. Lam,1 Ryan T.K. Kwok,1
Dingbin Liu,3 Dan Ding,2,* and Ben Zhong Tang1,4,6,*
At present, the most commonly used strategy for preparing multi-modality imaging
agents is to combine various components into one platform (all-in-one strategy) to
make use of their respective functions.21–25 Although effective, this method is hin-
dered by the complicated composition, reduced reproducibility and uncertain
pharmacokinetics, hence less accessible for clinical translation.26,27 Alternatively,
one-for-all organic agents with multiple imaging capacities in one molecule have
received more attention due to the lower complicity, simpler preparation, defined
structure, and far better reproducibility than the all-in-one agents.28,29 To our
knowledge, however, one-for-all organic agents with simultaneous fluorescence,
PA, and Raman imaging capabilities have been scarcely reported since it is consid-
erably hard to develop a molecular guideline to enable and boost every optical im-
aging efficacy at the same time. All the three imaging modalities stem from external
light excitation, e.g., fluorescence and PA are associated with the radiative and
nonradiative decay pathways from the excited state to the ground state, respec-
tively, while Raman signal originates from the relaxation of virtual energy state
(Scheme S1). The radiative and nonradiative pathways are expected to be greatly
impacted by the molecular motions (e.g., rotation, vibration, and twisting) that
could consume the excited-state energy, and Raman signal is a kind of molecular
vibration and rotation.18,30 These processes are competitive to each other, so it
is really difficult to simultaneously boost them in one organic molecule. Since the
aforementioned three optical imaging capacities and the corresponding photo-
physical processes are closely related to intramolecular motions, we wonder
whether organic molecules with rotation and vibration units can serve as a high-per-
1Department of Chemistry, The Hong Kong
forming fluorescence-PA-Raman triple-modality imaging agent, which has never
Branch of Chinese National Engineering
been explored before. Research Center for Tissue Restoration and
Reconstruction, Institute for Advanced Study, and
Department of Chemical and Biological
Molecular motions that play a pivotal role in determining many fundamental Engineering, The Hong Kong University of
physical and chemical processes hold stupendous potential for advancing the Science and Technology, Clear Water Bay,
biomedical field, as controllability and utilization of dynamic molecular motions Kowloon, Hong Kong, China
2State Key Laboratory of Medicinal Chemical
can lead to functional or smart materials with accurately tunable properties,
Biology, Key Laboratory of Bioactive Materials,
benefiting to precision medicine and personalized theranostics.31–33 For example, Ministry of Education, and College of Life
our recent studies about the aggregation-induced emission (AIE) luminogens Sciences, Nankai University, Tianjin 300071, China
3College of Chemistry, Research Center for
clearly demonstrate that intramolecular motions contribute greatly to the photo-
Analytical Sciences, State Key Laboratory of
physical energy dissipation pathways and that restriction of intramolecular mo- Medicinal Chemical Biology, and Tianjin Key
tions significantly promotes fluorescence in the aggregates.34–36 However, so Laboratory of Molecular Recognition and
Biosensing, Nankai University, Tianjin 300071,
far, there have been few reports on the design of multi-functional bioagents
China
for precision medicine by fully taking advantage of active intramolecular motion 4Center for Aggregation-Induced Emission,
after light absorption, as it is indeed challenging to command and unify micro- SCUT-HKUST Joint Research Institute, State Key
cosmic molecular dynamic behaviors to determine macroscopic biomedical Laboratory of Luminescent Materials and
Devices, South China University of Technology,
function and optimize the efficacy. This motivates us to develop advanced optical Guangzhou 510640, China
bioprobes with biomedical effectiveness not achievable by currently available 5These authors contributed equally
ones. 6Lead Contact
*Correspondence: dingd@nankai.edu.cn (D.D.),
In this contribution, we report for the first time that boosted fluorescence, PA, tangbenz@ust.hk (B.Z.T.)
and Raman properties can be integrated into one organic fluorophore, in which https://doi.org/10.1016/j.chempr.2019.07.015
Scheme 1. Schematic Illustration of the One-for-All Organic Agent for Image-Guided Surgery
The one-for-all agent can be used for comprehensive preoperative fluorescence and PA imaging of
tumors, and intraoperative fluorescence and Raman imaging of tiny residual tumors to boost cancer
surgery outcomes. ex, excitation light.
RESULTS
Synthesis, Characterization, and Photophysical Properties
The push-pull or donor-acceptor (D-A) approach, in which the electron-donating
and electron-withdrawing moieties are alternatively arranged along the conjugated
structure, is effective to reduce the bandgap.37,38 In this work, we employ alkoxy-
substituted triphenylamine (OTPA) as the donor and thiadiazoloquinoxaline (TQ)
as the acceptor to construct the NIR chromophores. The strong D-A interaction en-
sures efficient intramolecular charge transfer (ICT), which is beneficial to realizing
small electronic band gap and thus NIR absorption and emission. The octyloxy sub-
stitutes in triphenylamine unit could increase the electron-donating nature, as well as
endow the resultant compounds with good solubility and processability. Moreover,
the long side chains are designed to retain some room between the conjugated
backbones, which is favorable for intramolecular motions in aggregated state.39,40
A series of analogs with different substituted groups (i.e., phenyl, phenyl-alkyne,
and phenyl-alkyne-phenyl) in TQ core have been synthesized (Figure 1A) to investi-
gate their influence on the optical imaging properties in terms of fluorescence, PA,
and Raman. The synthetic route to OTPA-TQ molecules is presented in Scheme S2.
Key synthesis steps include Stille cross-coupling reaction between the tributyltin-
substituted OTPA (5) and the dibromo-molecule (6) to produce the dinitro-com-
pound (7) as a dark purple solid, followed by the iron-catalyst nitro reduction and
subsequent cyclization with benzils to obtain the final compounds. The benzil deriv-
atives (9–11) with different substitutes were prepared in advance. The intermediates
and final compounds are characterized by 1H NMR, 13C NMR, and high-resolution
mass spectrum (HRMS). Detailed synthesis processes and characterizations are
shown in the Supplemental Information (Figures S1–S22).
the molecules in THF (Figure S32). The absorption maxima of OTPA-TQ1-3 NPs are
centered at 684, 701, and 705 nm, respectively (Figure 2C; Table S1), which are red-
shifted slightly as compared with those in solution states. On the contrary, the PL
spectra of OTPA-TQ1-3 NPs are centered at 880, 897, and 895 nm, respectively (Fig-
ure 2D; Table S1). The hypsochromic shifts of NPs emission spectra for about 15 nm
when compared with those in THF solutions may be attributed to that the fluoro-
phoric molecules in NPs are surrounded by the same molecules with less polarity
than THF. The PL spectra of the compounds in toluene (Figure S29B) exhibit hypso-
chromic shifts of about 20 nm as compared to that of THF solution, which is similar as
the NPs form and confirms the influence of polarity effect.
state, while the nonradiative decay rates decrease significantly. In solution, the mol-
ecules undergo active intramolecular motions, which would consume the excited-
state energy and result in dominated nonradiative relaxation. In contrast, the molec-
ular environment in the aggregate state imposes higher structural rigidity, which
blocks the nonradiative decay channel of the excited state and the radiative one
opens, giving rise to increased PL efficiency.34,47 The highest fluorescent brightness
and aAIE value of OTPA-TQ3 NPs should be attributed to the most twisted molecular
structure, which could reduce the intermolecular interactions within NPs. PL excita-
tion (PLE) mapping was also performed to gain deep understanding about the exci-
tation-emission relationships, and PLE maps of the organic NPs (Figures 2E, S34, and
S35) manifest eligible excitation and emission in NIR region.
When comparing the PA amplitudes among the three OTPA-TQ NPs, as depicted in
Figure 3C, OTPA-TQ3 NPs exhibit the highest PA intensity, which is about 1.4-fold
higher than the other two counterparts NPs. This could be ascribed to that the large
phenyl-alkyne-phenyl rotors lead to stronger intramolecular motions43 and thus
generate stronger PA signal, agreeing well with Figure 3A. The higher absorption
coefficient of OTPA-TQ3 might also account for the pronounced fluorescence and
PA performance. The PA amplitude of OTPA-TQ NPs was also compared with the
well-known high-performing PA imaging agents including semiconducting polymer
NPs (SPNs) (Figure S36) and methylene blue (MB).15,49 Since MB, SPNs, and OTPA-
TQ1-3 NPs have similar absorption at about 680 nm (Figure S37), rational compari-
son in the same concentration (50 mM) was allowed using a 680 nm pulsed laser. As
shown in Figure 3C, under the same experimental condition, the PA amplitude of
OTPA-TQ3 NPs is 1.7-fold and 2.4-fold higher than that of SPNs and MB, respec-
tively. Furthermore, the PA intensity of OTPA-TQ3 NPs shows a good linear relation-
ship with the molar concentration of OTPA-TQ3 (Figure 3D), indicating the potential
for quantitative analysis.
continuous red light (650 nm, 200 mW cm 2) irradiation for 60 min, the absorption
and emission properties of all three NPs remain constant, whereas MB dye with
similar absorption maximum is easily photobleaching, as evidenced by the PL inten-
sity decreasing to 55% of the original value (Figure 5A). Additionally, reactive ox-
ygen and nitrogen species (RONS) are a kind of important signaling molecules
closely related to body health, which are also known to overexpress in many
diseased regions, e.g., cancer, inflammation, and cardiovascular diseases.57,58 As
a consequence, stable optical probes that are resistant to RONS are momentous
for in vivo disease detection. As presented in Figure 5B, all the OTPA-TQ1-3 NPs
show excellent resistance to various RONS. In contrast, the FDA-approved ICG is
severely destroyed in the presence of ClO and ,OH, which is likely due to the
degradation of alternatively arranged single-double bonds. We further studied
the probe stability under PA experiment condition. After exposure to 2.4 3 104
pulses (17.5 mJ cm 2 laser and 10 Hz pulse repetition rate), nearly no PA signal
loss is observed (Figure 5C), indicating good photostability and suitability for PA im-
aging. Noteworthy, the NPs also show good colloidal stability, as no precipitation is
observed after storage at room temperature for 2 weeks, and the average diameters
nearly do not change as well (Figure S38). Taken together, these results reveal that
the organic nanoagents possess superb stability with various treatments, which are
suitable for the long-term in vivo applications.
tumor-bearing mice were concurrently scanned by IVIS imaging system and small-
animal opt-acoustic tomography system (MOST) at designated time intervals. The
time-dependent in vivo non-invasive NIR fluorescence images are shown in Fig-
ure 6A, and the corresponding fluorescence intensity-time relationship in tumor is
depicted in Figure 6B, which reveal that the NIR fluorescence signal at tumor site be-
comes intense gradually as the time elapses stemming from the passive enhanced
permeability and retention (EPR) effect.59 The outstanding EPR effect of OTPA-
TQ3 NPs should be benefited from their appropriate size and surface chemistry. Be-
sides tumor, the reticuloendothelial system (RES) organs including liver and spleen
where the NPs are prone to accumulate are also lighted up (Figures 6C and S39).60 At
24 h post-injection, the fluorescence signal at tumor site reaches the maximum and
the tumor signal-to-background (surrounding normal skin autofluorescence) ratio is
as high as 9.2, which is considered to be very high according to the literatures.61
On the other hand, the mice were also imaged by PA instrument within 24 h study
duration. As shown in Figure 6D, the PA signal in tumor gradually amplifies over
time and arrives at the peak at 24 h post-injection, coinciding well with the trend
of time-dependent fluorescence imaging results (Figures 6A and 6B). Noteworthy,
the average PA signal in tumor at 24 h is 7.0 times higher than the background
(0 h) before NPs injection (Figure 6E), giving better performance than many high-
performing PA imaging agents.37,62 Both preoperative NIR fluorescence imaging
and PA imaging indicate that the OTPA-TQ3 NPs can detect the tumors in vivo in
an extremely high-contrast manner at 24 h post-injection, providing the surgeon
with important information on surgical plan.
To pursue precise surgical treatment, Raman imaging with microscopic resolution was
conducted in the suspicious areas with faint fluorescence. As illustrated in Figure 7B,
the OTPA-TQ3 NPs with strong Raman signal (2,215 cm 1) in the cell-silent region
can sensitively visualize the residual tumors and their boundaries to normal tissues by
Raman imaging with ‘‘yes-or-no’’ signature. Such excellent effectiveness of residual tu-
mor detection during surgery should be attributed to both the high Raman signal of
OTPA-TQ3 NPs and the innate zero-background nature of Raman imaging in cell-silent
region. It is noted that 94% of the tested tiny areas with Raman signal are confirmed as
tumors when consulting the H&E histological analysis (Figure 7C). As Raman imaging is
much faster than histological analysis, it holds great promise for intraoperative residual
tumor inspection.6,64 Noteworthy, the intraoperative fluorescence-Raman imaging with
OTPA-TQ3 NPs can clearly delineate tiny residual tumors after S1 with diameters of
about 450 mm (Figure S40). After demonstrating the existence of residual tumors, the
surgeon could perform the second surgery (S2) to remove the residual tumors until there
are no fluorescence and Raman signals (Figures 7D–7F).
The survival rates of mice after S1 (with fluorescence and Raman signals at the sur-
gical incision sites) and S2 (without any signals), respectively, were monitored with
the mice received no surgical treatment as the control. As shown in Figure 7G, the
mice without surgical treatment and only undergoing S1 all died within 40 days
post-surgery. In contrast, the 10 mice in S2 group survived 40 days, however,
2 mice were then dead on day 43 and 47 after surgery, respectively. The other
8 mice survived during 60-day study duration. Given that it has been well accepted
that 4T1 tumor model has aggressive metastatic potential,65 the influence of lung
metastasis on survival rates was assessed. In this experiment, the lung organ of
each dead mouse in the 3 groups was excised, sliced, and stained with H&E for his-
tological analysis. As displayed in Figures 7H and 7I, it is found that almost all the
dead mice in the Control and S1 groups suffer from lung metastases, as confirmed
by the H&E staining. Moreover, the primary tumors from mice in these two groups
also grew bigger as the time elapsed. Therefore, the mice in Control and S1
cohorts died probably attributed to both the lung metastases and primary tumor
growing.
On the other hand, for S2 group, since there was no primary tumor recurrence observed
for the 2 dead mice, the lung metastases were examined. As shown in Figure S41, obvious
lung metastases are observed, which should be the main cause of death for these 2 mice.
Furthermore, the other 8 surviving mice in S2 group were sacrificed at the end of the study
(on day 60 after surgery), and the histological analyses reveal neither primary tumor recur-
rence nor obvious lung metastases (Figure 7J). We then investigated the possible reason
for the less lung metastases in S2 group. Since the surgeries (both S1 and S2) were carried
out on day 9 after the 4T1 cancer cells were injected subcutaneously into the mouse axil-
lary space, the lung tissues were examined with H&E on day 9 post-cancer cell inocula-
tion. As shown in Figure S42A, the H&E-stained lung slices show negligible tumor metas-
tases on this day, implying that the lung metastases may not significantly occur at this time
point. It is also found that distinct lung metastases can be observed on day 21 after 4T1
cancer cell inoculation (Figure S42B). Therefore, the complete tumor resection was per-
formed at the relatively early stage of cancer, which would greatly reduce the risk of sub-
sequent lung metastases, leading to 8 of 10 mice in S2 group surviving 60 days.
To study the influence of agent dose on the imaging performance, different concen-
trations (0, 81, 162, 325, and 650 mM) of OTPA-TQ3 NPs with the same volume of
200 mL were intravenously injected into the tumor-bearing mice, and the PA, fluores-
cence and Raman imaging were investigated. To make a rational comparison, the
imaging was carried out in the same condition as indicated in the experimental pro-
cedures. Generally, the signal intensity intensifies with increased concentration (Fig-
ures S47 and S48). For preoperative PA imaging, the high concentration of 650 mM
can provide detailed information about tumor size in a high-contrast manner, while
other lower concentrations are not able to illuminate the tumor site clearly. The
intraoperative fluorescence imaging could only illuminate residual tumors with
the high-concentration nanoagent, possibly because there is tissue autofluores-
cence and a low NPs concentration in the tiny residual tumor nodules, while Raman
imaging can provide a better signal in a relatively low nanoagent concentration,
probably because of the zero-background signature in the cell-silent region. As a
DISCUSSION
We have developed a kind of one-for-all molecular agent for comprehensive image-
guided surgery application. The fluorescence, PA, and Raman properties in one organic
molecule are greatly impacted by the molecular structure and intramolecular motion, as
they have an effect on the photophysical properties, and the corresponding optical im-
aging performance. As compared with the other two compounds, OTPA-TQ3 with the
largest intramolecular rotation units has the most twisted 3D molecular structure and the
strongest AIE effect, benefiting to the highest NIR fluorescent brightness in aqueous
media. Moreover, the strong excited-state intramolecular motions and high absorption
coefficient endow OTPA-TQ3 with the strongest PA signal generation capability.
Furthermore, the phenyl-alkyne-phenyl units warrant OTPA-TQ3 NPs strong Raman
signal at 2215 cm 1 in the cell-silent region, and the intramolecular motions in high en-
ergy state after light excitation are demonstrated to significantly enhance the Raman
signal. Taking advantages of the high sensitivity of fluorescence imaging and good
spatial resolution and penetration depth of PA technique, the intravenously adminis-
trated OTPA-TQ3 NPs enable tumor detection preoperatively and then guidance of sur-
gical plan. Further intraoperative imaging during cancer surgery manifests that the
OTPA-TQ3 NPs can help the surgeon accurately remove all of the tiny residual tumors
by virtue of the fast, real-time, and sensitive fluorescence imaging and high-contrast
Raman imaging with zero background, which greatly prolong the lifetimes of mice
post-surgery. Moreover, the organic nanoprobe shows good biocompatibility, and no
side effect was observed from both the in vitro and in vivo tests. This work represents
the first example of boosting fluorescence-PA-Raman properties in one organic fluoro-
phore, which allows for accurate cancer imaging and resection, rendering great promise
for integrated multi-modality imaging applications.
There are still several aspects that can be considered for meeting the clinical trans-
lation of multi-modality optical imaging agent. First, the probes with longer excita-
tion and emission wavelengths would be better, for example, to increase the absorp-
tion and emission wavelength of the probes to the recently developed second NIR
window would enable larger penetration depth, and higher spatial resolution. Sec-
ond, other post-surgery treatment (e.g., immunotherapy) may be needed to
combine with the multi-modality image-guided precision surgery, especially for pa-
tients with metastases, to inhibit both the primary tumors and metastatic tumors
effectively. Third, new instrumentation that integrating the complex measurements
and data analyses in one platform could definitely facilitate in situ monitoring and
improve the performance of multi-modality imaging, benefiting for clinical use.
EXPERIMENTAL PROCEDURES
Materials and Characterizations
All the chemicals and reagents were purchased from chemical sources and were
used as received. The nuclear magnetic resonance (NMR) spectra were recorded
on a Bruker AV 400 spectrometer. HRMS were measured with a GCT premier
CAB048 mass spectrometer in matrix assisted laser desorption ionization-time of
flight (MALDI-TOF) mode. The theoretical calculation was carried out at the level
of B3LYP/6-31G* using DFT method with the Gaussian 09 program package (the
Photoacoustic Properties
The PA properties were studied by using a multi-spectral optoacoustic tomography
(iTheraMedical, Germany), which was equipped with a wavelength-tunable
(680–980 nm) optical parametric oscillator pumped by a Nd:YAG laser with excita-
tion pulses of 7 ns duration at a repetition rate of 10 Hz. The light from the fiber
covered an area of 4 cm2 with a maximum incident pulse energy of approximately
70 mJ (100 mJ, 70% fiber coupling efficiency). This generated an optical fluence
of 17.5 mJ cm 2, which was well within the safe exposures according to the American
National Standard for Safe Use of Lasers. The PA intensity was measured by finely
analyzing the regions of interest of acquired images. PA spectra of the NPs solutions
were obtained by recording the PA signals at different wavelengths from 680 nm to
950 nm (10 nm wavelength for each slice). The relationship between PA intensity and
NPs concentration was established by using various concentrations of NPs solutions
(10, 25, 50, 100, and 200 mM). The comparison of PA intensity of different agents
(50 mM) was conducted by the excitation of 680 nm pulsed laser. The probe stability
during PA experiment was evaluated by scanning OTPA-TQ3 NPs in a phantom
(50 mM) with 2.4 3 104 of laser pulses at 700 nm (17.5 mJ cm 2 laser and 10 Hz pulse
repetition rate).
Cytotoxicity Study
3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-tetrazolium bromide (MTT) assay was used
to evaluate the cytotoxicity of the NPs in different cell lines. 4T1 breast cancer cells,
NIH 3T3 cells and Detroit 551 human fibroblast cells were respectively harvested in a
logarithmic growth phase and seeded in 96-well plates (5000 cells per well with
100 mL suspension) for 24 h and grew to 80% confluence. Then the culture medium
was replaced with 100 mL of fresh culture medium containing OTPA-TQ3 NPs with
various concentrations (the concentrations based on OTPA-TQ3 are: 0 mM,
1.5 mM, 3 mM, 6 mM, 15 mM, and 30 mM), separately. After incubating for 24 h, the
culture medium was removed and the wells were washed three times with PBS,
and 100 mL of MTT dissolved in serum-free culture medium (0.5 mg/mL) was added
into each well. After 4 h, the MTT solution was removed cautiously and 100 mL of
DMSO was added into the wells, followed by gently shaking for 10 min. Then, the
absorbance of MTT was measured by a Bio-Rad 680 microplate reader at 490 nm
to evaluate the viability of cells inside.
Animal Experiments
All animal studies were conducted under the guidelines set by Tianjin Committee of
Use and Care of Laboratory Animals, and the overall project protocols were
approved by the Animal Ethics Committee of Nankai University.
Tumor-Bearing Mice
6-Week-old female BALB/c mice were obtained from the Laboratory Animal Center
of the Academy of Military Medical Sciences (Beijing, China). To establish the xeno-
graft 4T1 tumor-bearing mouse model, 4T1 breast cancer cells (1 3 106) suspended
in 30 mL of RPMI-1640 medium were injected subcutaneously into the right axillary
space of the BALB/c mouse. After about 9 days, mice with tumor volumes of about
80–120 mm3 were used subsequently.
Histological Analysis
After S1 and the intraoperative imaging with fluorescence and Raman techniques,
tissues at the operative sites were collected and fixed in 4% paraformaldehyde at
4 C overnight. Then the samples were embedded in paraffin, sliced at a thickness
of 5 mm, and the slices were stained with H&E, and imaged by an optical microscopy
(Leica QWin). After S2, the surgical sites were also examined by H&E staining in a
similar manner.
Statistical Analysis
Statistical analysis was performed by GraphPad Prism. Quantitative data were ex-
pressed as means G standard deviation (SD). One-way ANOVA and unpaired Stu-
dent’s t test were utilized for statistical analyses. p Value < 0.05 was considered sta-
tistically significant.
SUPPLEMENTAL INFORMATION
Supplemental Information can be found online at https://doi.org/10.1016/j.chempr.
2019.07.015.
ACKNOWLEDGMENTS
This work was supported by the National Science Foundation of China (51622305,
21788102, and 51873092), the National Basic Research Program of China
(2015CB856503), the Research Grants Council of Hong Kong (C6009-17G,
C2014-15G, A-HKUST605/16, 16308016, and 2018YFE0190200), the Innovation
and Technology Commission (ITC-CNERC14SC01 and ITS/254/17), the Funda-
mental Research Funds for the Central Universities, Nankai University, and the
AUTHOR CONTRIBUTIONS
D.D. and B.Z.T. conceived and designed the study. J.Q. synthesized and character-
ized the compounds. J.Q. and J.L. performed the NPs preparation and in vitro ex-
periments. J.L., R.L., and Q.L. performed the in vivo experiments. H.Z. provided
technical assistance with the theoretical calculation. J.Q., J.L., J.W.Y.L., R.T.K.K.,
D.L., D.D., and B.Z.T. analyzed the data and participated in the discussion. J.Q.,
J.L., D.D., and B.Z.T. contributed to the writing of this paper.
DECLARATION OF INTERESTS
The authors declare no competing interests.
photosensitivity. J. Am. Chem. Soc. 140, 2165– 37. Qi, J., Fang, Y., Kwok, R.T.K., Zhang, X., Hu, X., temperature phosphorescence. Chem 1,
2178. Lam, J.W.Y., Ding, D., and Tang, B.Z. (2017). 592–602.
Highly stable organic small molecular
24. He, X., Zhao, Z., Xiong, L.H., Gao, P.F., Peng, nanoparticles as an advanced and 48. Cai, X., Liu, J., Liew, W.H., Duan, Y., Geng, J.,
C., Li, R.S., Xiong, Y., Li, Z., Sung, H.H.-Y., biocompatible phototheranostic agent Thakor, N., Yao, K., Liao, L.-D., and Liu, B.
Williams, I.D., et al. (2018). Redox-active of tumor in living mice. ACS Nano 11, 7177– (2017). Organic molecules with propeller
AIEgen-derived plasmonic and fluorescent 7188. structures for efficient photoacoustic
core@shell nanoparticles for multimodality imaging and photothermal ablation of
bioimaging. J. Am. Chem. Soc. 140, 6904– 38. Cheng, K., Chen, H., Jenkins, C.H., Zhang, G., cancer cells. Mater. Chem. Front. 1, 1556–1562.
6911. Zhao, W., Zhang, Z., Han, F., Fung, J., Yang, M.,
Jiang, Y., et al. (2017). Synthesis, 49. Weber, J., Beard, P.C., and Bohndiek, S.E.
25. Ai, X., Ho, C.J.H., Aw, J., Attia, A.B.E., Mu, J., characterization, and biomedical applications (2016). Contrast agents for molecular
Wang, Y., Wang, X., Wang, Y., Liu, X., Chen, H., of a targeted dual-modal near-infrared-II photoacoustic imaging. Nat. Methods 13,
et al. (2016). In vivo covalent cross-linking of fluorescence and photoacoustic 639–650.
photon-converted rare-earth nanostructures imaging nanoprobe. ACS Nano 11, 12276–
for tumor localization and theranostics. Nat. 50. Lin, L., Tian, X., Hong, S., Dai, P., You, Q.,
12291.
Commun. 7, 10432. Wang, R., Feng, L., Xie, C., Tian, Z.Q., and
39. Ma, J., Liu, Z., Wang, Z., Yang, Y., Zhang, G., Chen, X. (2013). A bioorthogonal Raman
26. Fan, W., Yung, B., Huang, P., and Chen, X. Zhang, X., and Zhang, D. (2017). Charge reporter strategy for SERS detection of glycans
(2017). Nanotechnology for multimodal mobility enhancement for on live cells. Angew. Chem. Int. Ed. Engl. 52,
synergistic cancer therapy. Chem. Rev. 117, diketopyrrolopyrrole-based conjugated 7266–7271.
13566–13638. polymers by partial replacement of branching
51. Wei, L., Hu, F., Shen, Y., Chen, Z., Yu, Y., Lin,
alkyl chains with linear ones. Mater. Chem.
27. Ni, D., Ferreira, C.A., Barnhart, T.E., Quach, V., C.C., Wang, M.C., and Min, W. (2014). Live-cell
Front. 1, 2547–2553.
Yu, B., Jiang, D., Wei, W., Liu, H., Engle, J.W., imaging of alkyne-tagged small biomolecules
Hu, P., et al. (2018). Magnetic targeting of 40. Zhao, Z., Chen, C., Wu, W., Wang, F., Du, L., by stimulated Raman scattering. Nat. Methods
nanotheranostics enhances cerenkov Zhang, X., Xiong, Y., He, X., Cai, Y., Kwok, 11, 410–412.
radiation-induced photodynamic therapy. R.T.K., et al. (2019). Highly efficient
52. Yamakoshi, H., Dodo, K., Palonpon, A., Ando,
J. Am. Chem. Soc. 140, 14971–14979. photothermal nanoagent achieved by
J., Fujita, K., Kawata, S., and Sodeoka, M.
harvesting energy via excited-state
28. Lovell, J.F., Jin, C.S., Huynh, E., Jin, H., Kim, C., (2012). Alkyne-tag Raman imaging for
intramolecular motion within nanoparticles.
Rubinstein, J.L., Chan, W.C.W., Cao, W., Wang, visualization of mobile small molecules
Nat. Commun. 10, 768.
L.V., and Zheng, G. (2011). Porphysome in live cells. J. Am. Chem. Soc. 134, 20681–
nanovesicles generated by porphyrin bilayers 41. Cai, Y., Liang, P., Tang, Q., Yang, X., Si, W., 20689.
for use as multimodal biophotonic contrast Huang, W., Zhang, Q., and Dong, X. (2017). 53. Li, X., Jiang, M., Lam, J.W.Y., Tang, B.Z., and
agents. Nat. Mater. 10, 324–332. Diketopyrrolopyrrole-triphenylamine organic Qu, J.Y. (2017). Mitochondrial imaging with
nanoparticles as multifunctional reagents for combined fluorescence and stimulated Raman
29. Feng, G., and Liu, B. (2016). Multifunctional photoacoustic imaging-guided scattering microscopy using a probe of
AIEgens for future theranostics. Small 12, 6528– photodynamic/photothermal synergistic the aggregation-induced emission
6535. tumor therapy. ACS Nano 11, 1054–1063. characteristic. J. Am. Chem. Soc. 139, 17022–
30. Ng, K.K., and Zheng, G. (2015). Molecular 42. Qi, J., Sun, C., Li, D., Zhang, H., Yu, W., 17030.
interactions in organic nanoparticles for Zebibula, A., Lam, J.W.Y., Xi, W., Zhu, L., Cai, F., 54. Jansen, TlC., Snijders, J.G., and Duppen, K.
phototheranostic applications. Chem. Rev. et al. (2018). Aggregation-induced emission (2001). Interactioinduced effects in the
115, 11012–11042. luminogen with near-infrared-II excitation and nonlinear Raman response of liquid CS2: a
near-infrared-I emission for ultradeep intravital finite field nonequilibrium molecular
31. Qian, H., Cousins, M.E., Horak, E.H., Wakefield, two-photon microscopy. ACS Nano 12, 7936–
A., Liptak, M.D., and Aprahamian, I. (2017). dynamics approach. J. Chem. Phys. 114,
7945. 10910–10921.
Suppression of Kasha’s rule as a mechanism
for fluorescent molecular rotors and 43. Zong, L., Zhang, H., Li, Y., Gong, Y., Li, D., 55. Zheng, M., and Du, W. (2006). Phase behavior,
aggregation-induced emission. Nat. Chem. 9, Wang, J., Wang, Z., Xie, Y., Han, M., Peng, Q., conformations, thermodynamic properties,
83–87. et al. (2018). Tunable aggregation-induced and molecular motion of multicomponent
emission nanoparticles by varying isolation paraffin waxes: a Raman spectroscopy study.
32. Xie, S., Manuguri, S., Proietti, G., Romson, J., groups in perylene diimide derivatives Vib. Spectrosc. 40, 219–224.
Fu, Y., Inge, A.K., Wu, B., Zhang, Y., Häll, D., and application in three-photon
Ramström, O., et al. (2017). Design and fluorescence bioimaging. ACS Nano 12, 56. Troccoli, M., Belyanin, A., Capasso, F.,
synthesis of theranostic antibiotic nanodrugs 9532–9540. Cubukcu, E., Sivco, D.L., and Cho, A.Y. (2005).
that display enhanced antibacterial activity and Raman injection laser. Nature 433, 845–848.
luminescence. Proc. Natl. Acad. Sci. USA 114, 44. Qi, J., Sun, C., Zebibula, A., Zhang, H., Kwok,
8464–8469. R.T.K., Zhao, X., Xi, W., Lam, J.W.Y., Qian, J., 57. Dickinson, B.C., and Chang, C.J. (2011).
and Tang, B.Z. (2018). Real-time and high- Chemistry and biology of reactive oxygen
33. Zhang, J., Fu, Y., Han, H.H., Zang, Y., Li, J., He, resolution bioimaging with bright species in signaling or stress responses. Nat.
X.P., Feringa, B.L., and Tian, H. (2017). Remote aggregation-induced emission dots in Chem. Biol. 7, 504–511.
light-controlled intracellular target recognition short-wave infrared region. Adv. Mater. 30,
by photochromic fluorescent glycoprobes. e1706856. 58. Mao, D., Wu, W., Ji, S., Chen, C., Hu, F., Kong,
Nat. Commun. 8, 987. D., Ding, D., and Liu, B. (2017).
45. Hong, G., Antaris, A.L., and Dai, H. (2017). Chemiluminescence-guided cancer therapy
34. Mei, J., Leung, N.L.C., Kwok, R.T.K., Lam, Near-infrared fluorophores for biomedical using a chemiexcited photosensitizer. Chem 3,
J.W.Y., and Tang, B.Z. (2015). Aggregation- imaging. Nat. Biomed. Eng. 1, 0010. 991–1007.
induced emission: together we
shine, united we soar! Chem. Rev. 115, 46. Wan, H., Yue, J., Zhu, S., Uno, T., Zhang, X., 59. Qian, C., Yu, J., Chen, Y., Hu, Q., Xiao, X., Sun,
11718–11940. Yang, Q., Yu, K., Hong, G., Wang, J., Li, L., et al. W., Wang, C., Feng, P., Shen, Q.D., and Gu, Z.
(2018). A bright organic NIR-II nanofluorophore (2016). Light-activated hypoxia-responsive
35. Ding, D., Li, K., Liu, B., and Tang, B.Z. (2013). for three-dimensional imaging into biological nanocarriers for enhanced anticancer therapy.
Bioprobes based on AIE fluorogens. Acc. tissues. Nat. Commun. 9, 1171. Adv. Mater. 28, 3313–3320.
Chem. Res. 46, 2441–2453.
47. Zhao, W., He, Z., Lam, J.Y., Peng, Q., Ma, H., 60. Sun, Q., Zhou, Z., Qiu, N., and Shen, Y. (2017).
36. Qian, J., and Tang, B.Z. (2017). AIE luminogens Shuai, Z., Bai, G., Hao, J., and Tang, B.Z. (2016). Rational design of cancer nanomedicine:
for bioimaging and theranostics: from Rational molecular design for achieving nanoproperty integration and synchronization.
organelles to animals. Chem 3, 56–91. persistent and efficient pure organic room- Adv. Mater. 29, 28234430.
61. Liu, J., Chen, C., Ji, S., Liu, Q., Ding, D., Zhao, 63. Pirro, V., Alfaro, C.M., Jarmusch, A.K., Hattab, 65. Sagiv-Barfi, I., Kohrt, H.E., Czerwinski, D.K.,
D., and Liu, B. (2017). Long wavelength E.M., Cohen-Gadol, A.A., and Cooks, R.G. Ng, P.P., Chang, B.Y., and Levy, R. (2015).
excitable near-infrared fluorescent (2017). Intraoperative assessment of tumor Therapeutic antitumor immunity by
nanoparticles with aggregation-induced margins during glioma resection by checkpoint blockade is enhanced
emission characteristics for image-guided desorption electrospray ionization-mass by ibrutinib, an inhibitor of both BTK and
tumor resection. Chem. Sci. 8, 2782–2789. spectrometry. Proc. Natl. Acad. Sci. USA 114, ITK. Proc. Natl. Acad. Sci. USA 112, E966–
6700–6705. E972.
62. Pu, K., Mei, J., Jokerst, J.V., Hong, G., Antaris,
A.L., Chattopadhyay, N., Shuhendler, A.J., 64. Jermyn, M., Mok, K., Mercier, J., Desroches, 66. Liu, Z., Davis, C., Cai, W., He, L., Chen, X., and
Kurosawa, T., Zhou, Y., Gambhir, S.S., et al. J., Pichette, J., Saint-Arnaud, K., Bernstein, Dai, H. (2008). Circulation and long-term fate of
(2015). Diketopyrrolopyrrole-based L., Guiot, M.C., Petrecca, K., and Leblond, F. functionalized, biocompatible single-walled
semiconducting polymer nanoparticles for (2015). Intraoperative brain cancer carbon nanotubes in mice probed by Raman
in vivo photoacoustic imaging. Adv. Mater. 27, detection with Raman spectroscopy in spectroscopy. Proc. Natl. Acad. Sci. USA 105,
5184–5190. humans. Sci. Transl. Med. 7, 274ra19. 1410–1415.